Urology Center of Southern California

Murrieta, California 92563

5 studies enrolling now · 6 studies all time

What they study most

Bladder (Urothelial, Transitional Cell) Cancer, High-Risk Non-Muscle-Invasive Bladder Cancer, Intermediate Risk Non-Muscle Invasive Bladder Cancer, NMIBC, Non-Muscle Invasive Bladder Carcinoma, Non-muscle Invasive Bladder Cancer (NMIBC), Non-muscle-invasive Bladder Cancer, Prostate Cancer, Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent, Urothelial Carcinoma in Situ, Urothelial Carcinoma of the Urinary Bladder

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer — Recruiting now
• Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC — Recruiting now
• A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer — Completed
• A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC — Starting soon
• ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer — Available (expanded access)